nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Colorectal Cancer in Patients with Inflammatory Bowel Disease
|
Vagefi, Parsia A. |
|
2005 |
4 |
5 |
p. 313-319 7 p. |
artikel |
2 |
Evolution of FOLFOX Regimens in the Treatment of Advanced Colorectal Cancer
|
Reddy, G. Kesava |
|
2005 |
4 |
5 |
p. 296-299 4 p. |
artikel |
3 |
5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study
|
D'Andre, Stacy |
|
2005 |
4 |
5 |
p. 325-331 7 p. |
artikel |
4 |
Importance of Preclinical Investigations of the Integration of Capecitabine into Polychemotherapy Regimens
|
Danesi, Romano |
|
2005 |
4 |
5 |
p. 344- 1 p. |
artikel |
5 |
Long-Term Results of Local Excision with and Without Chemoradiation for Adenocarcinoma of the Rectum
|
Wentworth, Stacy |
|
2005 |
4 |
5 |
p. 332-335 4 p. |
artikel |
6 |
Lymphatic Mapping and Sentinel Node Analysis in Colon Cancer
|
Martinez, Steve R. |
|
2005 |
4 |
5 |
p. 320-324 5 p. |
artikel |
7 |
Staging of Colorectal Cancer: Past, Present, and Future
|
Horton, Janet K. |
|
2005 |
4 |
5 |
p. 302-312 11 p. |
artikel |
8 |
Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan
|
Cao, Shousong |
|
2005 |
4 |
5 |
p. 336-343 8 p. |
artikel |
9 |
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial
|
Reddy, G. Kesava |
|
2005 |
4 |
5 |
p. 300-301 2 p. |
artikel |
10 |
The Development of the FOLFOX Regimens as a Treatment Standard of Advanced Colorectal Cancer
|
Chu, Edward |
|
2005 |
4 |
5 |
p. 292- 1 p. |
artikel |